Zu "141505-33-1" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Levosimendan
Artikelnummer: Cay16128-50
Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C (EC50 = 9 nM), promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells (EC50 = 0.28 µM), and performs a cardioprotective function by prompting the opening of...
| Schlagworte: | (R)-Simendan, OR 1259, Simdax(R),... |
| Anwendung: | PDE3 inhibitor |
| CAS | 141505-33-1 |
| MW: | 280.3 D |
ab 78,00 €
Levosimendan
Artikelnummer: LKT-L1884.250
A Ca(2) sensitizer that increases contractile force of the myocardium by enhancing the sensitivity ofmyofilaments to calcium without increasing intracellular calcium concentration. It has been shown to reduce circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators.
| Anwendung: | Ca sensitizer |
| CAS | 141505-33-1 |
| MW: | 280,28 D |
ab 198,00 €
Levosimendan
Artikelnummer: TGM-T2530-100mg
Description: Levosimendan (OR1259) is a calcium sensitizer used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing...
| Schlagworte: | OR1855, OR1259 |
| Anwendung: | Cardiotonic, Phosphodiesterase inhibitor |
| CAS | 141505-33-1 |
| MW: | 280.28 D |
ab 31,00 €
Levosimendan
Artikelnummer: LKT-L1884.25
A Ca(2) sensitizer that increases contractile force of the myocardium by enhancing the sensitivity ofmyofilaments to calcium without increasing intracellular calcium concentration. It has been shown to reduce circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators.
| Schlagworte: | Simdax, Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-methyl-6- oxo-3-pyridazinyl)phenyl)hydrazone |
| Anwendung: | Ca sensitizer |
| CAS | 141505-33-1 |
| MW: | 280.28 D |
94,00 €
